Epstein Secrets

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

arns Of COVID-19 Disinformation Before Election. Hearst Television (10/8, Albert) reports National Counterintelligence and Security Center Director Bill Evanina "warned in a rare interview that 'more aggressive activity' to spread coronavirus disinformation is expected before the Nov. 3 election - and beyond

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "f

ricans-more-aggressive- coronavirus-disinformation-coming/34317312> (10/8, Albert) reports National Counterintelligence and Security Center Director Bill Evanina "warned in a rare interview that 'more aggressive activity' to spread coronavirus disinformation is expected before the Nov. 3 election — and beyond

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

arns Of COVID-19 Disinformation Before Election. Hearst Television (10/8, Albert) reports National Counterintelligence and Security Center Director Bill Evanina "warned in a rare interview that 'more aggressive activity' to spread coronavirus disinformation is expected before the Nov. 3 election - and beyond

Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4, story 8, 1:45, 6.1M), Tom Costello reported, "The NIH and drugmaker Eli Lilly are tonight looking for 2,000 volunteers for antibody drug trials to treat patients suffering from the ravages of COVID. One trial involves patients

cybersecurity agency "in partnership with the Center for Internet Security has been deploying software to election offices." Just a few weeks ago, Bill Evanina, director of the National Counterintelligence and Security Center, "released a statement noting foreign adversaries are seeking to compromise elect

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

arns Of COVID-19 Disinformation Before Election. Hearst Television (10/8, Albert) reports National Counterintelligence and Security Center Director Bill Evanina "warned in a rare interview that 'more aggressive activity' to spread coronavirus disinformation is expected before the Nov. 3 election - and beyond